296 related articles for article (PubMed ID: 22363635)
1. Exendin-4 improves steatohepatitis by increasing Sirt1 expression in high-fat diet-induced obese C57BL/6J mice.
Lee J; Hong SW; Chae SW; Kim DH; Choi JH; Bae JC; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Kim SW; Lee WY
PLoS One; 2012; 7(2):e31394. PubMed ID: 22363635
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of NAMPT aggravates high fat diet-induced hepatic steatosis in mice through regulating Sirt1/AMPKα/SREBP1 signaling pathway.
Wang LF; Wang XN; Huang CC; Hu L; Xiao YF; Guan XH; Qian YS; Deng KY; Xin HB
Lipids Health Dis; 2017 Apr; 16(1):82. PubMed ID: 28449683
[TBL] [Abstract][Full Text] [Related]
3. Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis.
Svegliati-Baroni G; Saccomanno S; Rychlicki C; Agostinelli L; De Minicis S; Candelaresi C; Faraci G; Pacetti D; Vivarelli M; Nicolini D; Garelli P; Casini A; Manco M; Mingrone G; Risaliti A; Frega GN; Benedetti A; Gastaldelli A
Liver Int; 2011 Oct; 31(9):1285-97. PubMed ID: 21745271
[TBL] [Abstract][Full Text] [Related]
4. GLP-1 receptor agonist promotes brown remodelling in mouse white adipose tissue through SIRT1.
Xu F; Lin B; Zheng X; Chen Z; Cao H; Xu H; Liang H; Weng J
Diabetologia; 2016 May; 59(5):1059-69. PubMed ID: 26924394
[TBL] [Abstract][Full Text] [Related]
5. SIRT1/HSF1/HSP pathway is essential for exenatide-alleviated, lipid-induced hepatic endoplasmic reticulum stress.
Zheng X; Xu F; Liang H; Cao H; Cai M; Xu W; Weng J
Hepatology; 2017 Sep; 66(3):809-824. PubMed ID: 28439947
[TBL] [Abstract][Full Text] [Related]
6. SIRT1 mediates the effect of GLP-1 receptor agonist exenatide on ameliorating hepatic steatosis.
Xu F; Li Z; Zheng X; Liu H; Liang H; Xu H; Chen Z; Zeng K; Weng J
Diabetes; 2014 Nov; 63(11):3637-46. PubMed ID: 24947350
[TBL] [Abstract][Full Text] [Related]
7. Exendin-4 attenuates endoplasmic reticulum stress through a SIRT1-dependent mechanism.
Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Cell Stress Chaperones; 2014 Sep; 19(5):649-56. PubMed ID: 24446069
[TBL] [Abstract][Full Text] [Related]
8. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice.
Li H; Xu M; Lee J; He C; Xie Z
Am J Physiol Endocrinol Metab; 2012 Nov; 303(10):E1234-44. PubMed ID: 22967499
[TBL] [Abstract][Full Text] [Related]
9. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice.
Ding X; Saxena NK; Lin S; Gupta NA; Anania FA
Hepatology; 2006 Jan; 43(1):173-81. PubMed ID: 16374859
[TBL] [Abstract][Full Text] [Related]
10. Isocaloric Pair-Fed High-Carbohydrate Diet Induced More Hepatic Steatosis and Inflammation than High-Fat Diet Mediated by miR-34a/SIRT1 Axis in Mice.
Li X; Lian F; Liu C; Hu KQ; Wang XD
Sci Rep; 2015 Nov; 5():16774. PubMed ID: 26608583
[TBL] [Abstract][Full Text] [Related]
11. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
[TBL] [Abstract][Full Text] [Related]
12. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
13. [The Preliminary Investigation of GLP-1 Receptor Agonist on Liver Steatosis in Obese Mice].
Wang X; He H; Liang LB; Zhang M; Li SY; Li SQ; An ZM; Huang HJ
Sichuan Da Xue Xue Bao Yi Xue Ban; 2017 Jan; 48(1):28-32. PubMed ID: 28612554
[TBL] [Abstract][Full Text] [Related]
14. Exendin-4 improves thermogenic capacity by regulating fat metabolism on brown adipose tissue in mice with diet-induced obesity.
Wei Q; Li L; Chen JA; Wang SH; Sun ZL
Ann Clin Lab Sci; 2015; 45(2):158-65. PubMed ID: 25887869
[TBL] [Abstract][Full Text] [Related]
15. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
[TBL] [Abstract][Full Text] [Related]
16. GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy.
Sharma S; Mells JE; Fu PP; Saxena NK; Anania FA
PLoS One; 2011; 6(9):e25269. PubMed ID: 21957486
[TBL] [Abstract][Full Text] [Related]
17. Exendin-4 regulates lipid metabolism and fibroblast growth factor 21 in hepatic steatosis.
Lee J; Hong SW; Park SE; Rhee EJ; Park CY; Oh KW; Park SW; Lee WY
Metabolism; 2014 Aug; 63(8):1041-8. PubMed ID: 24933399
[TBL] [Abstract][Full Text] [Related]
18. LB100 ameliorates nonalcoholic fatty liver disease
Chen XY; Cai CZ; Yu ML; Feng ZM; Zhang YW; Liu PH; Zeng H; Yu CH
World J Gastroenterol; 2019 Dec; 25(45):6607-6618. PubMed ID: 31832001
[TBL] [Abstract][Full Text] [Related]
19. Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice.
Trevaskis JL; Griffin PS; Wittmer C; Neuschwander-Tetri BA; Brunt EM; Dolman CS; Erickson MR; Napora J; Parkes DG; Roth JD
Am J Physiol Gastrointest Liver Physiol; 2012 Apr; 302(8):G762-72. PubMed ID: 22268099
[TBL] [Abstract][Full Text] [Related]
20. Metformin alleviates hepatosteatosis by restoring SIRT1-mediated autophagy induction via an AMP-activated protein kinase-independent pathway.
Song YM; Lee YH; Kim JW; Ham DS; Kang ES; Cha BS; Lee HC; Lee BW
Autophagy; 2015; 11(1):46-59. PubMed ID: 25484077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
